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Abstract-Cell killing potentiation by combined exposure to ionizing radiation and the 
cytotoxicant 1,3-bis(2-chloroethyl)-l-nitrosourea (BCNU) is of interest to radiation 
therapists because of implications to combined modality trials (radiation-therapy plus 
chemotherapy) for malignant gliomas. An additive-damage model is presented and used 
to predict cell killing potentiation after sequential exposure in vitro of rat 9L brain tumor 
cells to BCNU and X rays. Under the assumption of a Poisson distribution of lethal 
intracellular events, the average number of lethal lesions per cell can be represented 
by what is called the cumulative hazard. The cumulative hazard is used to arrive at a 
measure of cell-killing potentiation called the synergy factor (SF) which should be more 
sensitive than the conventional potentiation factor (PF) in the low-dose portion of the 
therapeutic dose range. Using a probabilistic modeling approach, it is shown that using 
cumulative hazards instead of doses to construct isobol curves, results similar to those 
arrived at with deterministic models for nonstochastic effects are obtained. 
INTRODUCTION 
The effects of combined exposure to different agents (cytotoxicants, mutagens, carcino- 
gens, drugs, etc.) are of interest in many areas of research[l-221. Much effort has been 
devoted to developing methods for predicting the effects of combinations of agents solely 
from their individual dose-effect relationships[ lo- 1 I, 14- 191. This study deals with pre- 
dicting cell killing by combined exposure of cells in vitro to a chemical cytotoxicant 
administered in combination with radiation and implications to therapy for brain tumors. 
There is much interest in the development of improved methods of treatment for brain 
tumors. Recent evidence suggest that a method of treatment could be combined therapy 
with the cytotoxic drug 1,3-bis(2-chloroethyl) I-nitrosourea (BCNU) and ionizing radia- 
tion[ I-91. When Fischer-344 rats with 9L brain tumor cells implanted intracerebrally were 
treated with daily fractions of BCNU and X rays, 5 days per week, for 2 weeks, the 
following was observed[j]: (1) there was a significant increase in life-span for the combined 
treatment scheme when compared to that observed for rats treated with the agents sep- 
arately; (2) the increase in life-span in the combined treatments depended on the time 
interval between the BCNU and X ray exposures as well as on the dose of BCNU. 
There is also clinical evidence which suggests that combined therapy with BCNU and 
radiation may increase the survival of patients with brain tumors[3]. However, schedules 
used clinically do not approach a cure because systemic toxicity and normal tolerance to 
radiation lead to termination of treatment before the number of tumors cells are reduced 
to a curative level[5]. However, if nontoxic doses of BCNU or some other drug, when 
administered in combination with ionizing radiation, could lead to synergistic cell-killing 
effects, then a combination therapy may be achievable which would provide for killing 
of more tumor cells during the course of the therapy while reducing the problem of sys- 
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temic toxicity. The increase in cell killing due to synergistic effects of combined exposure 
is called potentiation. 
To clarify the nature of cell killing potentiation by exposure to BCNU plus X rays, 
several in vitro studies were conducted by others in which rat 9L brain tumor cells were 
exposed to both agents[l, 4, 8, 91. Major findings were that the level of cell killing po- 
tentiation depends on the time interval between the in vitro exposure to BCNU and X 
rays, on the BCNU and X ray doses, and may depend on which agent is administered 
first. Maximum effectiveness was achieved when the BCNU exposure preceded the X 
ray exposure by 5-15 hrs. 
One objective of this study is to demonstrate that the use of a class of conditionally 
predictive models called additive-damage (or additive-action) models provide a theoretical 
framework for projecting cell-killing potentiation by combined exposure to ionizing ra- 
diation and nitrosoureas that are also known to damage DNA. A second objective is to 
demonstrate the usefulness of modeling at the level of the cumulative hazard when looking 
at interaction effects when stochastic processes are involved. Conditional on specific 
known cell survival functions for survival after exposure to individual agents, additive- 
damage models can be used to predict cell killing by combined exposure to two or more 
agents[lO, 111. Additive-damage models have been demonstrated to adequately predict 
cell killing in vitro by combined exposure to neutrons and X rays[ 1 I], alpha radiation and 
X rays[lOl, or BCNU and X rays[l I]. Cases where additive-damage models lead to linear 
isobolar relationships were recently discussed by Berenbaum[ 161. 
A generic additive-damage cell survival model is used to predict cell-kil!ing potentiation 
for killing of rat 9L brain tumor cells after sequential exposure in vitro to BCNU and X 
rays. The approach used is to model at the level of the cumulative hazard function H 
which is related to the cell survival probability S through the relationship S = exp[ - HI. 
For cell killing, the cumulative hazard is a measure of the average number of lethal events 
produced per cell at risk and depends on the dose. This definition is based on an assumed 
Poisson distribution of lethal events, with an average number of H lethal events per cell. 
For a Poisson distribution of lethal events, with an average of H per cell, the probability 
of no lethal events is exp[ - H], which corresponds to the survival probability. 
Leenhouts et a/.[91 have provided fitted curves for survival of rat 9L brain tumor cells 
exposed to BCNU or X rays separately. These fitted curves are used in this manuscript 
to obtain cumulative hazard estimators A, and I& for exposure to BCNU or X rays, 
respectively. The hat notation is used to indicate a function estimator or parameter 
estimate. 
For combined exposure to BCNU plus X rays, the overall cumulative hazard (or global 
hazard) can be estimated using the sum Hb + H, + h, where A accounts for cell killing 
potentiation. The function PF = exp[X] represents what is called the potentiation factor 
and takes on a value greater than one when cell killing potentiation occurs. With use of 
an additive-damage model, A can be arrived at from information about effects of exposure 
to BCNU or X rays separately. No information is needed on the effects of combined 
exposure. Because of this, additive-damage models are said to be conditionally predictive. 
Cell killing potentiation in the low-dose portion of the therapeutic dose range is of 
interest because of problems with systemic toxicity in patients at high drug doses and 
because of injury to normal tissue at high radiation doses. A measure of cell killing po- 
tentiation is proposed for in vitro cell killing studies which should be more sensitive in 
the low-dose portion of the therapeutic dose range than the potentiation factor. 
Using a probabilistic modeling approach, it is shown in the Appendix that, using dose- 
dependent cumulative hazards instead of doses to construct isobol curves, results similar 
to those arrived at with deterministic models are obtained. 
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1. ADDITIVE-DAMAGE MODELS FOR SEQUENTIAL EXPOSURE 
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The method described for predicting cell survival after sequential exposure to X rays 
and BCNU is based on the use of a family of models called additive-damage models. 
However, application of this type of model is not restricted to cell survival but has also 
been used to predict carcinogenic and mutagenic risks after combined exposure to high 
and low linear-energy-transfer (LET) radiations[ lo- 1 I]. Neutrons and alpha radiations 
represent high LET radiations while X ray and gamma radiations represent low LET 
radiations. High LET radiations are generally more hazardous than low LET radiations. 
Let S,(dj) represent the cell survival probability at dose dj of cytotoxicant j which is 
involved in a combined exposure along with cytotoxicant k. A dose d,T of cytotoxicant j 
is said to be an isoeffect (or equivalent) dose with respect to the dose dk of cytotoxicant 
k iflll] 
Sj(dj’) = Sk(dk). (1) 
The isoeffect dose is obtained by solving Eq. (1) for dj’ and depends on the type of 
model used to describe survival after exposure to agents j and k separately. Solutions 
have been derived for the different types of models most often used in the radiation biology 
field[lO]. Parameters of the survival functions for exposure to the agents individually must 
be estimated by fitting an assumed model to experimental data for cell survival. Toxicant- 
specific survival functions obtained in this manner are discussed in Sec. 2. 
Let S(dk, dj; t/cj) represent the cell survival probability after exposure to a dose dk 
followed, after a fixed time interval fkj, by exposure to dose dj. The time interval rkj is 
the time required for maximum yield of critical damage and is assumed to be known. 
Critical damage is considered to be any damage that could lead to death of the cell. For 
initial exposure to ionizing radiation, tkj may be quite short (less than an hour since 
significant repair of sublethal damage occurs in this time). For initial exposure to BCNU. 
fkj may be as long as j-13 hrs[4, 8, 91. It is assumed that sufficient time is allowed after 
exposure to the second agent for maximum yield of the critical damage it produces. Thus 
a second variable representing time after exposure to both agents is not necessary. 
Additive-damage models for cell survival have the following basic property: 
S(dkj dj; fkj) = S,(dj + dj’). (2) 
Note that tkj appears only on the left-hand side of Eq. (2). This is because the function 
Sj on the right-hand side is for exposure to a single dose of cytotoxicant j equal to dj i 
d;. Equation (2) is based on the assumption that doses dk and dj’ produce equivalent 
amounts of critical damage and, therefore, equivalent amounts of cell killing. Doses di 
and di’ are considered to produce equivalent amounts of critical damage only if they have 
the same critical target (e.g. DNA). The combined cell killing effect is evaluated by cal- 
culating the expected cell survival after exposure to a total dose equal to (dj i d,3 of 
cytotoxicant j when administered alone in a single exposure. The process of adding doses 
d’ and dy has been called isoaddition[ 121. 
Note that the solution to Eq. (2) depends only on the doses dj and dj’ of cytotoxicant 
j and the survival func!ion Sj. Thus one does not have to fit data for combined exposure 
to both cytotoxicants k and j. Conditional on a specified survival function Sj and isoeffect 
dose d,‘, use of an additive-damage model allows the prediction of the expected cell 
survival after combined exposure to cytotoxicants k andj. 
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When the order of application of the doses is reversed, use of an additive-damage model 
leads to the survival function. 
S(dj, d,; f,J = Sk(dk + d;). (3) 
Note that the time intervals fjk and tkj for maximum yield of critical damage may differ 
considerably. It is assumed that both tjk and tkj are known, otherwise use of additive- 
damage models could lead to systematic errors. 
Additive-damage models have a property which may be potentially useful for radiation 
therapy considerations in that S(dk, dj; fkj) may differ significantly from S(dj, dk; tjk)[lo- 
-1 I]. This suggests that the influence of the ordering of doses on cell-killing potentiation 
may be predicted using additive-damage models provided each agent involved in the 
combined exposure damages the same critical target (e.g. DNA). 
Additive-damage models should not be used when it is known that each agent acts 
independently. In such cases, the independent-effects model is more appropriate. 
2. TOXICANT-SPECIFIC SURVIVAL FUNCTIONS 
Leenhouts et a/.[91 have published cell survival functions for rat 9L brain tumor cells 
exposed to X rays or BCNU when administered alone. These survival functions can be 
used to arrive at estimators for the cumulative H by taking the natural logarithm of the 
survival function and multiplying the results by - 1. 
The cumulative hazard Hj for exposure to agentj can then be represented by the linear- 
quadratic relationship. 
Hj = ajdj + bjdj. (4) 
Parameters Uj and bj are both positive and dj is the agent-specific dose. Estimates for Uj 
and bj for cell killing (loss of colony-forming ability) by exposure in vitro of rat 9L brain 
tumor cells to X rays are given in Table 1 and are based on cell survival functions published 
by Leenhouts et a1.[9]. 
The cell survival probability associated with cumulative hazard Hj is 
Sj = exp[-Hi]. 
Estimates of aj and bj for cell killing by exposure in vitro of rat 9L 
to BCNU for 1 hour are given in Table 1 and are based on the cell 
published by Leenhouts er a1.[9]. 
Table 1. Model parameter estimates for loss 
of colony-forming ability among rat 9L brain 
tumor cells exposed in vitro to X rays, 
BCNU [2]. 
Agent Parameter estimate Unit 
(5) 
brain tumor cells 
survival function 
X rays % - = 0.100 Gy-’ 
X rays l7, = 0.011 Gy-’ 
BCNU” bb = 0.085 (&ml)-’ 
Q For a 1 hr exposure. The parameter ab was 
assumed to equal zero. 
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3. CUMULATIVE HAZARDS FOR SEQUENTIAL EXPOSURE 
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For modeling the quanta1 (i.e.. all-or-none type) effects of combined exposure to dif- 
ferent toxicants. it is sometimes preferable to model at the level of the cumulative hazard 
function or its derivative (hazard-rate)[ lo- 1 I, 3-31. One advantage of modeling at this 
level is that one can deal with simple sums, rather than complicated products which can 
come about when one is modeling at other levels. 
For sequential exposure to BCNU and X rays, there are two possibilities: (a) Initial 
exposure to BCNU followed by exposure to X rays; (b) initial exposure to X rays followed 
by BCNU. The notation H,k is used to represent the cumulative hazard for cell killing by 
initial exposure to cytotoxicant j followed after a time period t/L with exposure to cyto- 
toxicant k; where j and k can take on subscripts x or b to represent X rays or BCNU, 
respectively. For example, the cumulative hazard for cell killing by initial exposure to 
BCNU followed 15 hrs later (assumed to be the time for maximum yield of critical damage) 
by exposure to X rays is represented by Hb.<. A function used to estimate this cumulative 
hazard is represented by fib.<. 
For combined sequential exposure to cytotoxicant j followed by exposure to cytotox- 
icant k, Hjk can be given as 
Hjk = Hj + Hk + A,,, (6) 
where the interaction (cumulative) hazard function A,,, takes on the value of zero for 
independent effects, is greater than zero for synergistic effects, and is less than zero for 
antagonistic effects[ 10, 111. 
Conditional on an additive-damage model being correct, and a cumulative hazard for 
cell killing of the form represented by Eq. (j), the interaction hazard will have the form[ 10. 
111 
An interchange in the subscripts j and k in Eq. (7) can be used to demonstrate the 
expected asymmetry in the interaction effects. A different result is obtained when the 
subscripts are interchanged, indicating that one ordering of the doses would be expected 
to be more effective than the other. As already pointed out, such an asymmetric behavior 
could provide an advantage in radiation therapy. An asymmetry in the interaction effects 
of neutrons and X rays was reported for cell killing[26]. Greater cell killing power was 
achieved when the neutron exposed preceded the X ray exposure than for the reversed 
ordering of the exposures. Studies on celi killing by sequential exposure to alpha radiation 
and X rays did not demonstrate this asymmetry[27]. However, both of these results were 
predicted using additive-damage models[ 10-I 11. 
Functions for estimating the cumulative hazard for cell killing by sequential exposure 
of rat 9L brain tumor cells to BCNU followed 15 hours later with X rays, based on the 
use of an additive-damage model is given in Table 2. Cell killing refers to loss of colony 
forming ability in vitro. 
It was previously demonstrated[ 111 that the additive-damage model cumulative hazard 
in Table 2, for killing of rat 9L brain tumor cells by exposure to BCNU followed 15 hrs 
later with X rays, adequately predicted the data used by Leenhouts er n1.[9]. The predicted 
and observed cumulative hazards are given in Fig. 1. Also shown are corresponding 
survival fractions. Similar results were obtained with the fitted model of Leenhouts et al. 
but these are not shown. The natural logrithm of the surviving fraction multiplied by - 1 
represents the cumulative hazard. Assuming lethal cellular lesions have a Poisson distri- 
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Table 2. Cumulative hazard function estimators for loss of colony 
forming ability among tat 9L brain tumor cells exposed to BCNU and X 
rays*. 
Agent Cumulative Hazard Estimator 
X rays 
BCNU 
BCNU + X rays 
X rays + BCNUb 
gbr = -0.1 d, + (O.Old?, + 0.00374 &fzb)“2 
x *b = 0.538db (O.l& + O.Otld:)“’ 
a The X ray dose d, is in Gy. and the BCNU dose db is in ug,‘rnl. 
b Only applicable in cases where BCNU acts rapidly. Presently avail- 
able data indicate that BCNU acts slowly in vitro[4, 8, 91. However, re- 
lationship can be used as upper bound. 
bution, the cumulative hazard represents the average number of lethal lesions per cell at 
risk. For exposure to 1 t&ml BCNU followed by various X ray doses, cells on the average 
are predicted to have less than one lethal lesion except at X ray doses above 5-10 Gy. 
For exposure to 7.5 &ml BCNU followed by various X ray doses, cells on the average, 
are predicted to have more than 5 lethal lesions for all X ray doses. Results based on the 
independent effects model are also shown in Fig. 1. Using the independent effects model 
calculations as a reference, synergistic interaction effects are clearly demonstrated. It is 
demonstrated in Sec. 5 how use of these cumulative hazards can lead to a more sensitive 
measure of cell-killing potentiation in the low dose portion of the therapeutic dose range. 
4. ISOBOL CURVES 
The same functions used to construct the curves in Fig. 1 (additive damage and in- 
dependent effects models) can be used to construct isobol curves that give X ray and 
BCNU dose combinations for iso-survival levels. When isobol curves (with doses as the 
BCNU Concentration 
X-RAY DOSE (Gy) 
Fig. 1. Expected and observed cumulative hazard and surviving fraction after sequential exposure of rat 9L 
brain tumor cells. The negative logarithm of the surviving fraction represents the overall cumulative hazard. 
Smooth curves represent expected values based on an additive-damage model while the dashed curves are based 
on the independent effects model. Data points are from Leenhouts et aI.[9]. The figure was reproduced from 
an earlier publication[l 11. 
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Fig. 2. Isobol curves for in vitro iso-survival levels of 90%, 75%, 50%, 2_5%, and 10% for rat 9.L brain tumor 
cells exposed sequentially to BCNU followed by X rays. Smooth curves, which exclude interaction effects, are 
used as references. Some may incorrectly judge the shape of the curves as indicating antagonistic effects. 
abscissa and ordinate) are derived using deterministic models, it is usually assumed that 
linear isobols will be obtained if no interaction effects occur[l7]. As is shown in Fig. 2, 
curvilinear isobols can be obtained even when interaction effects are excluded for sto- 
chastic effects. The isobols constructed by assuming statistical independence (indepen- 
dent-effects probabilistic model) are not linear. Thus, when dealing with stochastic pro- 
cesses such as cell killing, mutagenesis, or carcinogenesis, one should not assume the 
isobol curves will be linear, in the absence of interaction effects, when doses are used as 
the abscissa and ordinate. 
As in Fig. 1, the displacement between the isobol curves in Fig. 2, based on the in- 
dependent-effects and additive damage model, represent a measure of the synergistic 
effects. At low doses, both models lead to similar isobols indicating an absence of sig- 
nificant synergistic effects. 
As shown in the Appendix using a probabilistic approach, linear isobols can be obtained 
using the independent-effects model when isobols are constructed using cumulative haz- 
ards as the abscissa and ordinate instead of dose. 
For stochastic processes such as cell killing, mutagenesis, and carcinogenesis, linear 
isobol curves will always be obtained when the following isoeffect relationship is used 
(for two agents): 
or 63) 
The variable Hk is the calculated cumulative hazard for agent k which combines with 
the known cumulative hazard Hj(di) for agentj to give an iso-survival level exp( - 4). For 
1346 B. R. Scorr 
0.0 
BCNU CUMJi_ATlVE HAZARD 
Fig. 3. Hypothetical isobol curves obtained using cumulative hazards for the abscissa and ordinate rather than 
doses. Curve shapes are shown for synergistic, antagonistic, and independent stochastic effects. The shapes of 
the curves correspond to those obtained using deterministic models[l7]. 
mutagenesis and carcinogenesis exp( - +) would represent the fraction not showing the 
effect. The agent-specific cumulative hazard Hj(dj) is assumed to be known at each dose 
of interest and cannot be less than zero or greater than C$ in Eq. (8). The variable Hk has 
the same constraints. 
As shown in the Appendix, the isoeffect relationship which includes interaction effects 
is 
Hk + Hjfdj) + Ajk(djj d/c) = +> 
where Ajk(dj, dk) accounts for the interaction effects. When Hk is plotted as a function of 
H,(dj), the curve obtained will differ from that obtained using Eq. (8) only where interaction 
effects occur. The isobol curve will intersect both axes at a value of r$ and will have 
upward concavity when synergistic effects occur and downward concavity when antago- 
nistic effects occur. Thus, isobols developed for stochastic processes using the cu- 
mulative hazard will have the same properties as those developed for deterministic models. 
This is shown more clearly in Fig. 3 using hypothetical curves. 
Isobol curves were obtained for killing of rat 9L brain tumor cells using the cumulative 
hazards instead of dose and are shown in Fig. 4. For low levels of hazard (or dose) the 
isobols are similar for the independent-effect model and additive-damage model indicating 
the absence of significant interaction effects. At moderate and high levels of hazard, 
synergistic effects are demonstrated. 
Since there is a one-to-one correspondence between agent-specific hazards and agent- 
specific doses, one could alternatively use corresponding agent-specific doses instead of 
agent-specific cumulative hazards on the axes leading to nonlinear axes in dose but with 
linear isobols in the absence of interaction effects. 
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Fig. 4. Isobol curves for in vitro killing of rat 9L brain tumor cells by sequential exposure to BCNU followed 
by X rays for total cumulative hazards of 0.105, 0.278, 0.693. 1 .-I, and 2.3. which correspond to the 90%. 75%. 
25%. and 10% survival levels used in Fig. 2, respectively. Smooth curves which exclude interaction effects are 
used as reference. 
5. MEASURES OF POTENTIATION 
Two measures of cell killing potentiation by combined exposure to X rays and BCNU 
are used in the radiation biology literature[ 1, 41: (a) Potentiation factor (PF), which is the 
survival fraction when exposed to X rays only divided by the survival fraction when the 
same dose of X rays is delivered in combination with BCNU after normalizing for cell 
killing by BCNU; (b) dose enhancement ratio (DER), which is the dose of X rays required 
to produce a specified level of cell killing divided by the dose of X rays required to achieve 
the same level of cell killing when administered in combination with BCNU. 
The SF provides a measure of synergistic interaction effects where as the DER does 
not. This is because a value greater than one for the DER can be obtained even when 
the two agents act independently. Furthermore, use of the DER leads to division by zero 
when the dose of the second agent is more cytotoxic than the single dose of radiation 
considered. 
A measure of potentiation is proposed which is more sensitive than the PF to cell- 
killing potentiation in the low dose portion of the therapeutic dose range. This measure 
is called the synergy factor (SF) and is obtained by dividing the total cumulative hazard 
for the combined exposure (synergistic effects included) by a reference cumulative hazard 
based on the independent effects model (i.e. Aj, = 0). 
Since Hjk represents the cumulative hazard for exposure to both agentsj and k, while 
Hj and Hk are agent-specific cumulative hazards, the SF is given by 
SF = Hjk-l(Hj + Hk), 
or (10) 
SF = (Hi + Hk + Ajk)/( Hj + Hx_). 
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Fig. 5. Synergy factor (SF) for loss of colony forming ability among rat 9L brain tumor cells after exposure in 
vitro to BCNU followed IS hrs later with X rays; based on use of an additive-damage model. Surface truncated 
to show curvature. 
Like the PF, which equals exp (AJ, the SF takes on value greater than one only when 
synergistic interaction effects occur (i.e. when & > 0). When the SF is equal to or less 
than one, no benefits of the combined exposure of cells over that which could be obtained 
by exposure to a single agent may be realized. A value of SF = 1.5 would indicate that 
on the average, 1.5 times more lethal lesions would be produced than if the two agents 
acted independently. 
As the cumulative hazard is a measure of the expected critical cell killing damage, it 
is also a measure of the cell killing power, assuming the cell killing power increases as 
the critical damage increases. The percentage of the total cell kiiling power (CKP) at- 
Fig. 6. Expected percentage of the total cell killing power (CKP) attributable to synergistic interaction effects 
associated with sequential exposure of rat 9.L cells to BCNU and X rays; based on use of an additive-damage 
model. Surface truncated to show curvature. 
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Table 3. Predicted Synergy Factors (SF) and Potentiation 
Factors (PF) for loss of colony forming ability among rat 9L 
brain tumor cells exposed in vitro to BCNU and X rays, based 
on additive-damage model. 
Doses 
Surviving 
X rays (GY) BCNU (&ml) fraction PF SF 
0.5 1 0.86 1.01 1.06 
0.5 2 0.66 1.03 1.07 
0.5 3 0.42 1.06 1.07 
1.0 1 0.81 1.02 1.09 
1.0 2 0.60 1.06 1.13 
1.0 3 0.37 1.12 1.12 
2.0 1 0.70 1.04 1.10 
2.0 2 0.50 1.12 1.20 
2.0 3 0.29 1.24 1.22 
3.0 I 0.59 1.05 1.11 
3.0 2 0.40 1.19 1.24 
3.0 3 0.23 1.39 1.28 
4.0 1 0.48 1.07 1.10 
4.0 2 0.32 1.26 1.25 
4.0 3 0.17 1.55 1.32 
tributable to synergistic interaction effects, conditional on SF > 1, is 
CKP = lOO(SF - l)/SF. (11) 
For SF = 2, 50% of the cell killing power will be expected to be due to synergistic effects 
associated with the combined exposure. When the CKP is equal to or not very much 
greater than zero, there may be no advantage of the combined exposure over that which 
can be achieved by exposure to a single agent even though the DER may be very much 
greater than one and interpreted by some as indicating potentiation. 
Surfaces for the SF, and CKP are given in Figs. 5-6 for cell killing by sequential 
exposure to BCNU and X rays based on the use of an additive-damage model. Doses are 
restricted to the therapeutic dose range[4]. Both surfaces were generated using SAS graph- 
ical software[28]. To demonstrate that the SF should be more sensitive than the PF in 
the low-dose portion of the therapeutic dose range, representative values are given in 
Table 3. For high doses, the PF should be more sensitive than the SF. 
6. INFLUENCE OF ORDERING OF DOSES 
Previous calculations[2] using additive-damage models, with the assumption that 
BCNU acts quickly in producing lethal intracellular damage, indicated that greater po- 
tentiation of cell killing should be achieved when the X ray exposure precedes the BCNU 
exposure than for reversing the ordering of the exposures. However, available evidence 
suggests that BCNU does not act quickly and may require 5-15 hours to produce its 
maximum critical damage in vitro. With such a long delay in action, almost all of the 
repairable X ray-induced damage would be repaired if the X ray exposure preceded the 
BCNU exposure and little or no benefit of the combined exposure would be realized. The 
repair halftime for X ray-induced sublethal damage is approximately 1 hr[24]. Thus, if 
BCNU acts slowly in producing critical damage, the highest potentiation of cell killing is 
likely achieved when the BCNU exposure precedes the X ray exposure. 
It is suggested that the greatest potentiation of cell killing may be achieved if one could 
select a drug which acts quickly in producing critical intracellular damage. If such a drug 
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was administered shortly after exposure to X rays, sublethal damage produced by the X 
ray exposure would be available for interaction with that produced by the drug. 
At present, there is no explanation as to why BCNU acts slowly in producing critical 
damage in studies of cell killing in vitro. Research is needed to clarify this question and 
to determine if the time course of action is the same in vivo as in vitro. 
CONCLUSIONS 
It was demonstrated that the use of an additive-damage model provides a theoretical 
framework for predicting cell-killing potentiation by exposure to ionizing radiation ad- 
ministered in combination with a nitrosourea compound that is also known to damage 
DNA. Predicted survival of 9L rat brain tumor cells after sequential exposure to BCNU 
and X rays, which was arrived at by using an additive-damage model, was demonstrated 
to be in good agreement with available data. 
Use of additive-damage models for cell killing by combined exposure in vitro to ionizing 
radiation and a chemical cytotoxicant may assist researchers in selecting the types of 
radiation and types of cytotoxic drugs which would lead to greater potentiation of cell 
killing in the therapeutic dose range. They can also be used as an aid in the design of 
experimental protocols for cell killing by combined exposure to cytotoxicants. 
A synergy factor (SF) is proposed, which is more sensitive than the PF to cell killing 
potentiation in the low dose portion of the therapeutic dose range. A formula was provided 
which is based on the SF that can be used to arrive at a quantitative estimate of the 
contribution of synergistic effects to the total cell killing power. Usefulness of the cu- 
mulative hazard in constructing isobol curves to show interaction effects was also 
demonstrated. 
Research is needed to clarify why BCNU acts slowly in vitro in producing critical cell- 
killing damage and whether or not the same time course of action occurs in vivo. With 
a slow-acting drug that damages the same critical target as X rays, greater cell killing 
potentiation would be expected when exposure to the drug precedes exposure to X rays 
because sublethal damage produced by the drug would be available for interacting with 
that produced by X rays. For quick-acting drugs that damage the same critical target as 
X rays, greater cell killing potentiation may be obtained when the X ray exposure precedes 
the exposure to the drug. 
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APPENDIX: CONSTRUCTION OF ISOBOLS 
The approach used is based on the probabilistic interpretation of the survival curve and is jus- 
tifiable because cell killing is a stochastic process. Only sequential exposure to two agents j and 
k, in that order, is treated. The time interval tj~ between exposures is the same as in the text but 
is omitted to simplify the notation used. While the present application is to cell killing, the same 
approach can be used for other stochastic processes including mutagenesis and carcinogenesis. 
Let the cell lethality dose d_ of agent j have the cumulative distribution function P,(d,). AISO let 
the corresponding function for agent X- be P,(d,). For combined exposure to the two agents. let the 
joint cumulative distribution function for lethality be P(dj, d,). Corresponding survival probabilities 
at doses J and K of agents j and k, respectively, are give by: 
S_J{J) = P,( dj > J) (Al) 
Sk(K) = Pp(dl, > K) (AZ) 
S(J, K) = P(dj > J, d/, > K). (A3 
The form Eq. (A3) takes on will depend on whether or not interaction effects occur. If statistical 
independence is assumed (independent-effects model) for agents j and X-. then: 
S(J, K) = P,{dj > J)Pk(dk > K). (-44) 
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Using the alternative hazard-function representation one gets: 
SCJ, K) = exp[ -H,(J) - H:(K)] (AS) 
for agent-specific cumulative hazards H,(J) and Hk(K). Equation (A5) is appropriate when no in- 
teraction effects occur. The total cumulative hazard H(J, K) for the combined exposure is just the 
sum H,(J) + HIi of the agent specific cumulative hazards. 
Equation (X3) can also be represented in the equivalent hazard-function form, which includes 
interaction effects, given by: 
S(J, K) = ew[ - H,tJ) - HAK) - Aj!JJ, K)], (A6) 
where Ajk(J, K) has the same definition as in the text and takes on none zero values only when 
interaction effects occur. 
For an iso-survival level exp[ - 61, and for variable doses dj, an isoeffect relationship can be 
obtained for no interaction effects given by: 
HI = + - H,(dj), (A7) 
where Hk now represents a variable that depends on known values 4 and with H,(dj) representing 
the independent variable. The variable Hk is clearly a linear function of H,(dj) with an intercept of 
4 on both axes and a slope of - 1. Both Hk and H,{dj) have the constraints that neither can exceed 
4 nor be less than zero. Thus, when Hk is plotted on rectilinear graph paper vs Hj(dj)v a straight 
line isobol curve is always obtained which intersects both hazard-function axes at +. 
Equation (A7) can be generalized to any number of agents by replacing H,(dj) with the appropriate 
sum which excludes the one agent used as dependent variable. 
Unlike isobols based on dose, isobols based on the cumulative hazard are always straight lines 
when interaction effects are excluded. When interaction effects do not occur, isobols obtained using 
doses as the abscissa and ordinate will be linear only when the agent-specific cumulative hazards 
are linear in dose. 
The cumulative hazard representation of isobols provides a simple way of demonstrating syn- 
ergistic or antagonistic effects. This can be seen from the isoeffect relationship when interaction 
effects occur given by: 
HL = 6 - Hj(dj) - Ajk( dj, d,) 648) 
where dk is the dose which when given with dj leads to the cumulative hazard 4. When synergistic 
effects occur, Eq. (A8) will yield values for Hk less than obtained using Eq. (A7). Values greater 
than those obtained using Eq. (A7) will arise when antagonistic effects occur. Like the independent 
effects case, the isobol curve must intersect both cumulative hazard axes at 4 so that both kjk(O, 
dk) and Ajk(dj, 0) equal zero. 
Rearranging Eq. (A7) and dividing by 4 leads to: 
H~/c$ + Hjfdj)/+ = 1 (‘49) 
which is the stochastic equivalence to the deterministic isobol relationship developed by Beren- 
baum[l5] for noninteracting agents. Defining isoeffect doses di and d; such that: 
H,id;) = Hk(d;) = +, 
then Eq. (A9) is identical to: 
HkIHk(d;) + H,{dj)lH,(dj) = 1. (A101 
